Impact of Out-of-Pocket Cost on Herpes Zoster Vaccine Uptake: An Observational Study in a Medicare Managed Care Population

Impact of Out-of-Pocket Cost on Herpes Zoster Vaccine Uptake: An Observational Study in a Medicare Managed Care Population

Herpes zoster (HZ) vaccination is approved for adults aged 50+ for the prevention of HZ, but it is underutilized. The objective of this study was to evaluate the association between out-of-pocket cost and HZ vaccine utilization. Adults aged 65 or older enrolled for at least 12 months in Medicare Adv...

Full description

Bibliographic Details
Main Authors: Zhuliang Tao, Yong Li, Stephen Stemkowski, Kelly D. Johnson, Camilo J. Acosta, Dongmu Zhang, A. Mark Fendrick
Format: Article
Language:English
Published: MDPI AG 2018-11-01
Series:Vaccines
Subjects:
out-of-pocket costs
herpes zoster vaccine
vaccination rate
utilization
abandonment
Online Access:https://www.mdpi.com/2076-393X/6/4/78

Similar Items

Similar Items